Experienced in Chronic T-Cell Leukemia (CTCL)

Hideo M. Koh

Osaka, JP 
Experienced in Chronic T-Cell Leukemia (CTCL)
Osaka, JP 
OverviewLocationsClinical Research

Overview

Hideo Koh practices in Osaka, Japan. Mr. Koh is rated as an Experienced expert by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). His top areas of expertise are Febrile Neutropenia, Agranulocytosis, Hemophagocytic Lymphohistiocytosis, Bone Marrow Transplant, and Bone Marrow Aspiration.

His clinical research consists of co-authoring 140 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Chronic T-Cell Leukemia (CTCL).

Gender
Male

Locations

Osaka, Japan
Other Locations
Asahi, 5458585, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

An Open-Label Single-Arm Phase 1 Study Evaluating Safety of Itacitinib in Combination With Corticosteroids for the Treatment of Steroid-Naive Acute Graft-Versus-Host Disease in Japanese Subjects
An Open-Label Single-Arm Phase 1 Study Evaluating Safety of Itacitinib in Combination With Corticosteroids for the Treatment of Steroid-Naive Acute Graft-Versus-Host Disease in Japanese Subjects
Enrollment Status: Completed
Publish Date: March 03, 2020
Intervention Type: Drug
Study Phase: Phase 1

140 Total Publications

Phase II study of the triple combination of rabbit ATG, ciclosporin and eltrombopag in patients with transfusion-dependent aplastic anaemia: West Japan Hematology Study Group (W-JHS) AA02 trial.
Phase II study of the triple combination of rabbit ATG, ciclosporin and eltrombopag in patients with transfusion-dependent aplastic anaemia: West Japan Hematology Study Group (W-JHS) AA02 trial.
Journal: British journal of haematology
Published: August 04, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Koh's expertise for a condition
ConditionClose
    View All 13 Advanced Conditions
    View All 45 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile